Tra2-alpha: A Protein with Potential as A Drug Target and Biomarker

Target Name: TRA2A

NCBI ID: G29896

TRA2A

Tra2-alpha: A Protein with Potential as A Drug Target and Biomarker

Tra2-alpha is a protein that is expressed in various tissues of the body, including the brain, heart, kidneys, and intestines. It is a key regulator of the immune response and has been implicated in a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of Tra2-alpha is its role in the regulation of immune cell function. It is a transcription factor that regulates the expression of genes involved in immune response, and it has been shown to play a key role in the development and maintenance of immune tolerance.

In addition to its role in immune regulation, Tra2-alpha is also involved in a number of other processes in the body. For example, it is involved in the regulation of cell death, and has been shown to play a key role in the regulation of cell apoptosis. It is also involved in the regulation of cell signaling, and has been shown to play a key role in the regulation of cell proliferation.

Tra2-alpha has also been shown to be involved in a number of diseases, including cancer. For example, it has been shown to be involved in the regulation of the development and progression of cancer, and has been shown to play a key role in the regulation of cancer cell metastasis.

In addition to its involvement in disease, Tra2-alpha is also an attractive drug target. Because it has been shown to play a key role in a number of diseases, and its regulation by various signaling pathways makes it a potential target for small molecules.

Tra2-alpha has also been shown to have a number of potential therapeutic applications. For example, it has been shown to be involved in the regulation of the immune response, and has been shown to play a key role in the development and maintenance of immune tolerance. This makes it a potential target for therapies that aim to enhance or restore the immune response.

Tra2-alpha has also been shown to be involved in the regulation of cell death, and has been shown to play a key role in the regulation of cell apoptosis. This makes it a potential target for therapies that aim to enhance or restore cell death regulation.

In addition to its potential therapeutic applications, Tra2-alpha is also a potential biomarker. Because it is involved in a number of processes in the body, it has been shown to be a potential indicator of disease, and its levels have been proposed as a potential diagnostic biomarker.

Overall, Tra2-alpha is a protein that has the potential to be a drug target or biomarker. Its role in immune regulation and its involvement in a number of diseases make it a promising target for small molecules, and its potential as a biomarker make it an attractive option for diagnostic applications. Further research is needed to fully understand its role and potential as a drug target and biomarker.

Protein Name: Transformer 2 Alpha Homolog

Functions: Sequence-specific RNA-binding protein which participates in the control of pre-mRNA splicing

The "TRA2A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRA2A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets